Abstract:Influenza vaccines, which are recommended by the World Health Organization (WHO), are the most effective preventive measure against influenza virus infection. Madin–Darby canine kidney (MDCK) cell culture is an emerging technology used to produce influenza vaccines. One challenge when purifying influenza vaccines using this cell culture system is to efficiently remove impurities, especially host cell double-stranded DNA (dsDNA) and host cell proteins (HCPs), for safety assurance. In this study, we optimized ion-exchange chromatography methods to harvest influenza viruses from an MDCK cell culture broth, the first step in influenza vaccine purification. Bind/elute was chosen as the mode of operation for simplicity. The anion-exchange Q chromatography method was able to efficiently remove dsDNA and HCPs, but the recovery rate for influenza viruses was low. However, the cation-exchange SP process was able to simultaneously achieve high dsDNA and HCP removal and high influenza virus recovery. For the SP process to work, the clarified cell culture broth needed to be diluted to reduce its ionic strength, and the optimal dilution rate was determined to be 1:2 with purified water. The SP process yielded a virus recovery rate exceeding 90%, as measured using a hemagglutination units (HAUs) assay, with removal efficiencies over 97% for HCPs and over 99% for dsDNA. Furthermore, the general applicability of the SP chromatography method was demonstrated with seven strains of influenza viruses recommended for seasonal influenza vaccine production, including H1N1, H3N2, B (Victoria), and B (Yamagata) strains, indicating that the SP process could be utilized as a platform process. The SP process developed in this study showed four advantages: (1) simple operation, (2) a high recovery rate for influenza viruses, (3) a high removal rate for major impurities, and (4) general applicability.

Optimization of culture conditions for culturing of influenza virus H1N1 in MDCK cells and its purification

Optimization of cell culture for H9N2 subtype AIV and establishment of high-yield cell strain

Research on influenza virus cultured in MDCK cells

Comparison of Influenza Virus Titers Cultured in Vero and MDCK Cells

A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal

Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Rational Design of Medium Supplementation Strategy for Improved Influenza Viruses Production Based on Analyzing Nutritional Requirements of Mdck Cells

A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9)

Research on Multiplication of the H9N2 Subtype Avian Influenza Virus in Large-Scale Microcarrier-Based MDCK Cell Culture System

Highly Efficient Production of an Influenza H9N2 Vaccine Using MDCK Suspension Cells

Conversion of MDCK Cell Line to Suspension Culture and its Appli cation for Influenza Virus Production

Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor

Effects of TOI on H1N1 Virus Propagation in MDCK Cell Culture

Establishment and Detection of H1N1 Influenza Virus Adapted Monoclonal MDCK Cell Bank

Preliminary Optimization of Production Condition of Rabies Virus with MDCKCells Cultured in Serum-free Medium

Optimization of procedure for cleavage of influenza virus

Effect of Cell Density and Nutrition Supply on Cell-specific Virus Yields of Influenza Virus H1N1

Semi-perfusion Cultures of Suspension MDCK Cells Enable High Cell Concentrations and Efficient Influenza A Virus Production.

The Screening and Mechanism of Influenza-Virus Sensitive MDCK Cell Lines for Influenza Vaccine Production

Preparation of High-titer Lentivirus and Optimization of the Infection Conditions for Human Primary T cells

Novel, Real-Time Cell Analysis for Measuring Viral Cytopathogenesis and the Efficacy of Neutralizing Antibodies to the 2009 Influenza A (h1n1) Virus